Qing Yun Moyeam tea leaves — subject of thousands of peer-reviewed scientific studies on Myricetin
64+ Peer-Reviewed Citations

Medical Sources

Every claim Pureami Tea Company makes is grounded in published, peer-reviewed medical literature. Below are the sources — all available free at PubMed.com.

Our Commitment to Transparency

The three names — Myricetin, DiHydroMyricetin, and Ampelopsin — all refer to the same flavonol. Search any of them on PubMed.com and you will find a substantial body of evidence. Qing Yun Moyeam produces this compound at 30–40% by plant weight, versus 3–6% for ordinary grades.

We do not cherry-pick studies. We have never made a claim not supported by the published literature. All citations below link directly to their source on PubMed or the original journal.

Medical research laboratory — Myricetin and Moyeam tea studies published on PubMed
Scientific journal alongside Qing Yun Moyeam tea — peer-reviewed research on flavonols

Qing Yun Moyeam

Ampelopsis Grossedentata — Myricetin / DiHydroMyricetin / Ampelopsin

1 studies

Glioma / Brain Cancer

23.
Ampelopsin inhibits human glioma through inducing apoptosis and autophagy dependent on ROS generation and JNK pathway

PubMed

Ampelopsin (Myricetin) triggered cancer cell death in human brain tumor (glioma) cells through multiple simultaneous pathways, showing strong anticancer activity.

Disclaimer: The research cited above is provided for educational purposes only and reflects the findings of independent researchers. Pureami Tea Company does not claim that Moyeam diagnoses, treats, cures, or prevents any disease. These statements have not been evaluated by the FDA. Consult your healthcare provider before making any changes to your diet or supplement regimen.